These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 21358357)

  • 1. Whole genome analysis from microdissected tissue revealed adult supratentorial grade II-III gliomas are divided into clinically relevant subgroups by genetic profile.
    Hirose Y; Sasaki H; Miwa T; Ohba S; Ikeda E; Abe M; Ikeda S; Kobayashi M; Kawase T; Hasegawa M; Yoshida K
    Neurosurgery; 2011 Aug; 69(2):376-90. PubMed ID: 21358357
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Subgrouping of gliomas on the basis of genetic profiles.
    Hirose Y; Sasaki H; Abe M; Hattori N; Adachi K; Nishiyama Y; Nagahisa S; Hayashi T; Hasegawa M; Yoshida K
    Brain Tumor Pathol; 2013 Oct; 30(4):203-8. PubMed ID: 23604523
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Integrated molecular analysis suggests a three-class model for low-grade gliomas: a proof-of-concept study.
    Marko NF; Prayson RA; Barnett GH; Weil RJ
    Genomics; 2010 Jan; 95(1):16-24. PubMed ID: 19835948
    [TBL] [Abstract][Full Text] [Related]  

  • 4. World Health Organization grade II-III astrocytomas consist of genetically distinct tumor lineages.
    Hattori N; Hirose Y; Sasaki H; Nakae S; Hayashi S; Ohba S; Adachi K; Hayashi T; Nishiyama Y; Hasegawa M; Abe M
    Cancer Sci; 2016 Aug; 107(8):1159-64. PubMed ID: 27196377
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic stratification of patients with anaplastic gliomas according to genetic profile.
    Dehais C; Laigle-Donadey F; Marie Y; Kujas M; Lejeune J; Benouaich-Amiel A; Pedretti M; Polivka M; Xuan KH; Thillet J; Delattre JY; Sanson M
    Cancer; 2006 Oct; 107(8):1891-7. PubMed ID: 16986124
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Allelic losses at 1p36 and 19q13 in gliomas: correlation with histologic classification, definition of a 150-kb minimal deleted region on 1p36, and evaluation of CAMTA1 as a candidate tumor suppressor gene.
    Barbashina V; Salazar P; Holland EC; Rosenblum MK; Ladanyi M
    Clin Cancer Res; 2005 Feb; 11(3):1119-28. PubMed ID: 15709179
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular classification of diffuse cerebral WHO grade II/III gliomas using genome- and transcriptome-wide profiling improves stratification of prognostically distinct patient groups.
    Weller M; Weber RG; Willscher E; Riehmer V; Hentschel B; Kreuz M; Felsberg J; Beyer U; Löffler-Wirth H; Kaulich K; Steinbach JP; Hartmann C; Gramatzki D; Schramm J; Westphal M; Schackert G; Simon M; Martens T; Boström J; Hagel C; Sabel M; Krex D; Tonn JC; Wick W; Noell S; Schlegel U; Radlwimmer B; Pietsch T; Loeffler M; von Deimling A; Binder H; Reifenberger G
    Acta Neuropathol; 2015 May; 129(5):679-93. PubMed ID: 25783747
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genomic aberrations in diffuse low-grade gliomas.
    Dahlback HS; Gorunova L; Brandal P; Scheie D; Helseth E; Meling TR; Heim S
    Genes Chromosomes Cancer; 2011 Jun; 50(6):409-20. PubMed ID: 21412929
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gene expression-based classification of malignant gliomas correlates better with survival than histological classification.
    Nutt CL; Mani DR; Betensky RA; Tamayo P; Cairncross JG; Ladd C; Pohl U; Hartmann C; McLaughlin ME; Batchelor TT; Black PM; von Deimling A; Pomeroy SL; Golub TR; Louis DN
    Cancer Res; 2003 Apr; 63(7):1602-7. PubMed ID: 12670911
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intrinsic gene expression profiles of gliomas are a better predictor of survival than histology.
    Gravendeel LA; Kouwenhoven MC; Gevaert O; de Rooi JJ; Stubbs AP; Duijm JE; Daemen A; Bleeker FE; Bralten LB; Kloosterhof NK; De Moor B; Eilers PH; van der Spek PJ; Kros JM; Sillevis Smitt PA; van den Bent MJ; French PJ
    Cancer Res; 2009 Dec; 69(23):9065-72. PubMed ID: 19920198
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of genomic alterations associated with glioma progression by comparative genomic hybridization.
    Weber RG; Sabel M; Reifenberger J; Sommer C; Oberstrass J; Reifenberger G; Kiessling M; Cremer T
    Oncogene; 1996 Sep; 13(5):983-94. PubMed ID: 8806688
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular classification defines 4 prognostically distinct glioma groups irrespective of diagnosis and grade.
    Mur P; Mollejo M; Hernández-Iglesias T; de Lope ÁR; Castresana JS; García JF; Fiaño C; Ribalta T; Rey JA; Meléndez B
    J Neuropathol Exp Neurol; 2015 Mar; 74(3):241-9. PubMed ID: 25668564
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-resolution genome-wide mapping of genetic alterations in human glial brain tumors.
    Bredel M; Bredel C; Juric D; Harsh GR; Vogel H; Recht LD; Sikic BI
    Cancer Res; 2005 May; 65(10):4088-96. PubMed ID: 15899798
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Histological and molecular classification of gliomas].
    Figarella-Branger D; Colin C; Coulibaly B; Quilichini B; Maues De Paula A; Fernandez C; Bouvier C
    Rev Neurol (Paris); 2008; 164(6-7):505-15. PubMed ID: 18565348
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Update on the molecular biology of gliomas: towards a pathomolecular classification of gliomas].
    Idoate MA; Echeveste J
    Rev Neurol; 2007 Feb 16-28; 44(4):217-24. PubMed ID: 17311212
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Loss of heterozygosity on chromosomes 1 and 19 in cases of primary brain tumour].
    Born PW; Broholm H; Laursen H
    Ugeskr Laeger; 2006 Oct; 168(44):3813-6. PubMed ID: 17118240
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular voting for glioma classification reflecting heterogeneity in the continuum of cancer progression.
    Fuller GN; Mircean C; Tabus I; Taylor E; Sawaya R; Bruner JM; Shmulevich I; Zhang W
    Oncol Rep; 2005 Sep; 14(3):651-6. PubMed ID: 16077969
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multidimensional scaling of diffuse gliomas: application to the 2016 World Health Organization classification system with prognostically relevant molecular subtype discovery.
    Cimino PJ; Zager M; McFerrin L; Wirsching HG; Bolouri H; Hentschel B; von Deimling A; Jones D; Reifenberger G; Weller M; Holland EC
    Acta Neuropathol Commun; 2017 May; 5(1):39. PubMed ID: 28532485
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuron navigator 3 alterations in nervous system tumors associate with tumor malignancy grade and prognosis.
    Carlsson E; Krohn K; Ovaska K; Lindberg P; Häyry V; Maliniemi P; Lintulahti A; Korja M; Kivisaari R; Hussein S; Sarna S; Niiranen K; Hautaniemi S; Haapasalo H; Ranki A
    Genes Chromosomes Cancer; 2013 Feb; 52(2):191-201. PubMed ID: 23097141
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Papillary glioneuronal tumors: a review of clinicopathologic and molecular genetic studies.
    Myung JK; Byeon SJ; Kim B; Suh J; Kim SK; Park CK; Chung CK; Chang KH; Park SH
    Am J Surg Pathol; 2011 Dec; 35(12):1794-805. PubMed ID: 22020040
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.